| Literature DB >> 35518767 |
Somayeh Tajik1, Hadi Beitollahi2, Fariba Garkani Nejad2, Mohadeseh Safaei2, Kaiqiang Zhang3, Quyet Van Le4, Rajender S Varma5, Ho Won Jang6, Mohammadreza Shokouhimehr6.
Abstract
This review summarizes the progress that has been made in the past ten years in the field of electrochemical sensing using nanomaterial-based carbon paste electrodes. Following an introduction into the field, a first large section covers sensors for biological species and pharmaceutical compounds (with subsections on sensors for antioxidants, catecholamines and amino acids). The next section covers sensors for environmental pollutants (with subsections on sensors for pesticides and heavy metal ions). Several tables are presented that give an overview on the wealth of methods (differential pulse voltammetry, square wave voltammetry, amperometry, etc.) and different nanomaterials available. A concluding section summarizes the status, addresses future challenges, and gives an outlook on potential trends. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 35518767 PMCID: PMC9054518 DOI: 10.1039/d0ra03672b
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Schematic illustration of the stepwise fabrication process nickel nanoparticles modified CPE. Reprinted with permission from ref. 137 Copyright (2016) Royal Society of Chemistry.
Fig. 2Schematic representation of the CPE modified with GO and EDDPT as modifiers simultaneous determination of EP, AC and DA. Reprinted with permission from ref. 143 Copyright (2017) Elsevier.
Fig. 3Schematic of preparation of different modified electrodes with CdSe QD modified/MWCNT in 4 steps. Reprinted with permission from ref. 160 Copyright (2017) Elsevier.
Fig. 4Schematic illustration of glycine polymer and MWCNTs/CPE fabrication. Reprinted with permission from ref. 162 Copyright (2018) Electrochemical Science Group, University of Belgrade.
Selected applications of CPEs in biological species and pharmaceuticals compounds analysis using DPV
| Analyte | Modifier | Linear range | Detection limit | Ref. |
|---|---|---|---|---|
| Glutathione | Trichloro(terpyridine)ruthenium( | 0.6–56.8 μM | 0.3 μM |
|
| Gallic acid | SiO2 nanoparticles | 8.0 × 10−7 to 1.0 × 10−4 M | 2.5 × 10−7 M |
|
| Gallic acid | Zirconia nanoparticles/choline chloride/gold nanoparticles (ZrO2NPs–ChCl–AuNPs) | 0.22–55 μM | 25 nM |
|
| Gallic acid | TiO2 NPs | 2.5 × 10−6 to 1.5 × 10−4 M | 9.4 × 10−7 M |
|
| Citric acid | MIL-101(Fe) | 5.0 to 100 μM | 4.0 μM |
|
| Dopamine |
| 0.08–20.0 μM | 3.14 × 10−8 M |
|
| Dopamine | Graphene oxide (GO)/lanthanum (La) complex | 0.01–400.0 μM | 0.32 nM |
|
| Epinephrine | Carbon nanotube (CNT)/molybdenum( | 0.09 to 750.0 μM | 49 nM |
|
| Epinephrine | Hydrophilic ionic liquid 1-methyl-3-butylimidazolium bromide [MBIDZ]Br/carbon nanotube (CNT) | 0.3–450 μM | 0.09 μM |
|
| Epinephrine | Graphene oxide (GO)/2-(5-ethyl-2,4-dihydroxyphenyl)-5,7-dimethyl-4 | 1.5–600.0 μM | 0.65 μM |
|
| Epinephrine | 2,2′-[1,2-Butanediylbis(nitriloethylidyne)]-bishydroquinone (BBNBH)/TiO2 nanoparticles | 1.0–600.0 μM | 0.2 μM |
|
| Epinephrine | ZrO2 nanoparticles | 2.0 × 10−7 to 2.2 × 10−3 M | 9.5 × 10−8 M |
|
| Norepinephrine | ZrO2 nanoparticles | 1.0 × 10−7 to 2.0 × 10−3 M | 8.95 × 10−8 M |
|
| Norepinephrine | Ferrocene dicarboxylic acid (FCD)/carbon nanotube(CNT) | 0.03–500.0 μM | 22.0 nM |
|
| Norepinephrine | 2,2′-[1,2-Ethanediylbis (nitriloethylidyne)]-bis-hydroquinone (EBNBH)/carbon nanotube(CNT) | 0.1–1100.0 μM | 8.2 × 10−8 M |
|
| Levodopa | Polyglycine/zinc oxide nanoparticles/multi-walled carbon nanotubes PG/ZnO/MWCNTs | 5.0–500.0 μM | 0.08 μM |
|
| Levodopa | 2,7-Bis(ferrocenylethyl)fluoren-9-one (2,7-BF)/carbon nanotube (CNT) | 0.1–700.0 μM | 58 nM |
|
|
| MgO nanoparticle/acetylferrocene (AF) | 0.1–700.0 μM | 30.0 nM |
|
| Arginine | CdSe quantum dot (QD)/multi-walled carbon nanotube (MWCNT) | 0.287 to 33 670 μM | 0.081 μM |
|
| Alanine | 0.158 μM | |||
| Methionine | 0.094 μM | |||
| Cysteine | 0.116 μM | |||
| Tryptophan | Mesoporous silica nanoparticles (MSNs) | 0.05–600 μM | 1.13 × 10−8 M |
|
| Tyrosine | 0.3–600.0 μM | 4.97 × 10−8 M | ||
| Tryptophan | ZnFe2O4 nanoparticles | 0.1–200.0 μM | 0.04 μM |
|
| Tyrosine | 0.4–175.0 μM | 0.10 μM | ||
| Melatonin | SnO2–Co3O4@rGO nanocomposite/ionic liuid (SnO2–Co3O4@rGO/IL) | 0.02–6.00 μM | 4.1 nM |
|
| Tryptophan | 4.1–3.2 nM | 3.2 nM | ||
| Isoproterenol | Multiwall carbon nanotube (MWCNT)/ionic liquid (1-butyl-3-methylimidazolium hexafluoro phosphate ([C4mim]-[PF6])) (IL) | 1.0–520 μM | 0.85 μM |
|
| Isoproterenol | 1-(4-Bromobenzyl)-4-ferrocenyl-1 | 6.0 × 10−8 to 7.0 × 10−4 M | 12.0 nM |
|
| Isoproterenol | Ferrocenemonocarboxylic acid (FMA)/carbon nanotube (CNT) | 0.5–50.0 μM | 0.2 μM |
|
| Isoproterenol | 2,7-Bis(ferrocenyl ethyl)fluoren-9-one (2,7-BF)/carbon nanotube (CNT) | 0.08–700.5 μM | 26.0 ± 2 nM |
|
| Buprenorphine | Molecularly imprinted polymer (MIP)/nanoparticles multiwalled carbon nanotubes (MWCNTs) | 1 nM to 50 μM | 0.6 nM |
|
| Acetaminophen | Zinc ferrite nanoparticles (ZnFe2O4 NPs) | 6.5–135 μM | 0.4 μM |
|
| Epinephrine | 5–100 μM | 0.7 μM | ||
| Melatonin | 6.5–145 μM | 3.0 μM | ||
| Melatonin | Al2O3-supported palladium nanoparticles | 6.0 nM to 1.4 mM | 21.6 nM |
|
| Dopamine | 50 nM to 1.45 mM | 36.5 nM | ||
| Acetaminophen | 40 nM to 1.4 mM | 36.5 nM |
Selected applications of CPEs in biological species and pharmaceuticals compounds analysis using SWV
| Analyte | Modifier | Linear range | Detection limit | Ref. |
|---|---|---|---|---|
| Glutathione |
| 0.004–340 μM | 1.0 nM |
|
| Glutathione | MgO/SWCNTs/2-chloro- | 0.05–700.0 μM | 10 nM |
|
| Glutathione | Ag–ZnO nanoplates/2-chlorobenzoyl ferrocene (2-CBF) | 5.0 × 10−8 to 2.0 × 10−4 M | 20.0 nM |
|
| Glutathione | Ethynylferrocene (EF)/NiO/MWCNT nanocomposite | 0.01–200 μM | 0.006 μM |
|
| Dopamine | CdTe quantum dots | 7.5 × 10−8 to 6.0 × 10−4 M | 2.1 × 10−8 M |
|
| Norepinephrine | ZnO/CNTs nanocomposite/ionic liquid (1,3-dipropylimidazolium bromide) (ZnO/CNTs/IL) | 5.0 × 10−8 to 4.5 × 10−4 M | 2.0 × 10−8 M |
|
| Levodopa | Graphene nanosheets, 1-(4-bromobenzyl)-4-ferrocenyl-1 | 5.0 × 10−8 to 8.0 × 10−4 M | 1.5 × 10−8 M |
|
| Levodopa | Graphite oxide (GrO) and β-cyclodextrin (CD) | 1.0–20 μM | 0.065 μM |
|
| Levodopa | Graphene/ethyl 2-(4-ferrocenyl-[1,2,3]triazol-1-yl)acetate (EFTA) | 0.2–0.4 mM | 0.07 μM |
|
| Tyrosine | Reduced graphene oxide (rGO)/zinc oxide nanocomposite | 0.1–400 μM | 0.07 μM |
|
|
| TiO2 nanoparticles/quinizarine (QZ) | 0.8–140.0 μM | 0.76 μM |
|
| Isoproterenol | 5-Amino-3′,4′-dimethyl-biphenyl-2-ol (5ADB)/carbon nanotube | 4.0 × 10−7 to 9.0 × 10−4 M | 2.0 × 10−7 M |
|
| Methyldopa | Multiwalled carbon nanotubes (MWCNT)/ | 0.5–165.5 μM | 0.2 μM |
|
| Methyldopa | 5-Amino-2′-ethyl-biphenyl-2-ol (5AEB)/carbon nanotubes (CNTs) | 0.1–210.0 μM | 48.0 nM |
|
Selected applications of CPEs in biological species and pharmaceuticals compounds analysis using CHA, amperometry and LSV
| Analyte | Modifier | Electrochemical method | Linear range | Detection limit | Ref. |
|---|---|---|---|---|---|
| Ascorbic acid | 4-Aminobenzoic acid/herringbone carbon nanotubes (4ABA–hCNTs) | CHA | 0.065–1000.0 μM | 0.065 μM |
|
| Selegiline | Nickel nanoparticles | Amperometry | 5 × 10−6 to 1 × 10−4 | 4.0 × 10−6 M |
|
| Pramipexole | 5 × 10−8 to 1 × 10−6 | 4.5 × 10−8 M | |||
|
| Y2O3 nanoparticles supported on nitrogen-doped reduced graphene oxide (N-rGO) | Amperometry | 1.3 to 720 μM | 0.8 μM |
|
| Tyrosine | Glycine polymer/multi-walled carbon nanotubes (MWCNTs) | LSV | 0.2–400 μM | 0.07 μM |
|
Fig. 5Schematic representation of the CPE modified with clinoptilolite nano-particles were modified by hexadecyltrimethyl ammonium bromide surfactant and dithizone. Reprinted with permission from ref. 198 Copyright (2017) Elsevier.
Selected applications of CPEs to environment pollution analysis
| Analyte | Modifier | Electrochemical method | Linear range | Detection limit | Ref. |
|---|---|---|---|---|---|
| Fomesafen | Carbon nanotube (CNT) | SWV | 0.30–40 mg L−1 | 0.089 mg L−1 |
|
| Methyl parathion | ZrO2-nanoparticles | SWV | 5.0–3000.0 ng mL−1 | 2.0 ng mL−1 |
|
| Diazinon | Carbon nanotubes (CNTS) | DPV | 1 × 10−10 to 6 × 10−8 M | 4.5 × 10−10 M |
|
| Cd( | Bismuth nanoparticles | SWASV | 1–100 ppb | 0.81 ppb |
|
| Pb( | 1–100 ppb | 0.65 ppb | |||
| Ni( | 10–150 ppb | 5.47 ppb | |||
| Cd2+ | Antimony nanoparticles (SbNPs)/multiwalled carbon nanotubes (MWCNT) | SWASV | 10.0–60.0 μg L−1 | 0.77 μg L−1 |
|
| Pb2+ | 0.65 μg L−1 | ||||
| Pb2+ | Gold nanoparticles (Au NPs) | SWASV | 50–500 μg L−1 | 9.178 μg L−1 |
|
| Cd2+ | 200–700 μg L−1 | 86.327 μg L−1 | |||
| Cu2+ | 200–700 μg L−1 | 85.373 μg L−1 | |||
| Cd2+ | Graphene/TMU-16-NH2([Zn2(NH2-BDC)2(4-bpdh)]·3DMF) metal–organic framework (MOF) [graphene/MOF (TMU-16-NH2)] | DPV | 0.7–120 μg L−1 | 0.2 μg L−1 |
|
| Cu2+ | Silica nanoparticles/Schiff base ligand (L/SiO2 NPs) | SWASV | 4.0–400.0 ng mL−1 | 0.28 ng mL−1 |
|
| Cd2+ | 5.0–700.0 ng mL−1 | 0.54 ng mL−1 | |||
| Hg2+ | Carbon ionic liquid/ion imprinted polymeric (IIP) nanobeads | DPV | 0.5 nM to 2.0 μM | 0.1 nM |
|
| Sn2+ | Clinoptilolite nano-particles (CNP)/hexadecyltrimethyl ammonium bromide surfactant (HDTMA)/dithizone (DZ) CNP/HDTMA/DZ | SWV | 1 × 10−8 - 1 × 10−2 M | 9 × 10−9 M |
|
| Silver( | Poly(methylene disulfide) nanoparticles (PMDSNPs) | DPASV | 3.0 × 10−12 to 1.0 × 10−9 M | 1.0 × 10−13 M |
|
| Silver( | Magnetic silver ion imprinted polymer nanoparticles (mag-IIP-NPs) Fe3O4@SiO2@IIP | DPV | 0.05–150 μg L−1 | 15 ng L−1 |
|
| Sulfite | Benzoylferrocene (BF)/ionic liquid (n-hexyl-3-methylimidazolium hexafluoro phosphate)/graphene nano-sheets | SWV | 5.0 × 10−8 to 2.5 × 10−4 M | 20.0 nM |
|
| Hydrazine | Ionic liquid (2-(4-oxo-3-phenyl-3,4-dihydroquinazolinyl)- | SWV | 7.0 × 10−8 to 5.0 × 10−4 M | 40.0 nM |
|
| Sulfite | Ferrocene (FC)/multiwall carbon nanotubes (MWCNTs) | SWV | 0.4–120.0 μM | 0.1 μM |
|
| Hydroxylamine | Benzoylferrocene (BF)/carbon nanotubes (CNTs) | SWV | 0.9–400.0 μM | 0.1 μM |
|
| Hydrazine | 3-(4-Amino-3-hydroxy-biphenyl-4-yl)-acrylic acid/ZrO2 nanoparticles (ZrO2 NPs) | SWV | 2.5 × 10−8 to 5.0 × 10−5 M | 14 nM |
|
| Hydrazine | TiO2 nanoparticles/quinizarine (TiO2 NPs/QZ) | DPV | 0.5–1900.0 μM | 77 nM |
|
| Hydroxylamine | TiO2 nanoparticles/quinizarine (TiO2 NPs/QZ) | DPV | 1.0–400.0 μM | 0.173 μM |
|
| Hydrazine | TiO2 nanoparticles/Mn( | SWV | 3 × 10−8 to 4.0 × 10−4 M | 10.0 nM |
|
| Hydroxylamine | Carbon nanotubes and 2,7-bis(ferrocenyl ethyl) fluoren-9-one (2,7-BF) | SWV | 5.0 × 10−8 to 5.0 × 10−4 M | 15.0 nM |
|
| Hydroxylamine | 1,1-Bis(phenylacetyl)ferrocenele/NiO/CNTs nanocomposite (1,1-BPF/NiO/CNTs) | SWV | 0.5–250.0 μM | 0.2 μM |
|
| Hydroxylamine | CdO nanoparticles (CdO/NPs) | SWV | 0.09–650.0 μM | 0.06 μM |
|
| Hydroxylamine | Promazine hydrochloride (PHC)/multiwall carbon nanotube (MWCNT) | DPV | 0.17–10.0 mM | 1.4 nM |
|
| Hydroxylamine | 8,9-Dihydroxy-7-methyl-12 | SWV | 0.09–350 μM | 0.04 μM |
|
| Hydrazine | ZnO/CNTs nanocomposite/ | LSV | 0.02–550.0 μM | 8.0 nM |
|
| Hydrazine | Gold-copper bimetallic nanoparticles supported on nano P zeolite (Au–Cu/NPZ) | CV | 0.01–150 mM | 0.04 μM |
|
| Hydrazine | Silver-doped zeolite L nanoparticles (Ag/L) | CV | 10 μM to 4.0 mM | 1.5 μM |
|
| Hydrazine | β-Nickel hydroxide nanoplatelets | Amperometry | 1.0–1300.0 μM | 0.28 μM |
|
| Nitrite | Chitosan-functionalized silver nanoparticles/multiwalled carbon nanotube (chit-AgNPs/MWCNT) | Cyclic voltammograms | 100 nM to 50 μM | 30 nM |
|
| Paracetamol | SnO2/SnS nanocomposite | DPV | 1.0 to 36.0 μM | 0.06 μM |
|
An overview on nanomaterials commonly used in CPEs
| Nanomaterial | Features | Ref. |
|---|---|---|
| Carbon nanotubes (CNTs) | Good electrical conductivity, high chemical stability, high mechanical strength, high surface area, high ability to mediate electron transfer reactions with electroactive species in solution |
|
| Graphene | Extremely large specific surface area, good electrical conductivity, high electrocatalytic activity, strong mechanical strength, extremely high thermal conductivity, good biocompatibility, good hydrophilicity and dispersibility in water, high electron mobility at room temperature |
|
| CNTs based nanocomposite | Improve the electrical and mechanical properties of the composites by CNTs, possess the properties of individual CNTs, metal-NPs, metal oxide- NPs,… with a synergistic effect, excellent catalytic properties of nanoparticles without losing any of the electronic properties of CNTs |
|
| ZnO NPs | Wide band gap (3.37 eV), large excitation binding energy (60 eV), high exciton, biocompatibility, low-cost synthesis, non-toxicity, better electrochemical activities, chemical and photochemical stability, high-electron communication features |
|
| SiO2 NPs | Large active surface area and high accumulation efficiency |
|
| TiO2 NPs | Good biocompatibility, high conductivity, low cost, optical transparency |
|
| ZrO2 NPs | Thermal stability, biocompatibility, chemical inertness, and affinity for the groups containing oxygen, affinity for phosphate groups, good conductivity |
|
| MgO NPs | Good electrical conductivity |
|
| ZnFe2O4 NPs | Interesting electronic and magnetic properties, chemical and thermal stability, large specific surface area, low bandgap and high conductivity |
|
| CdO NPs | Lower density, higher surface area, and distinct optical property |
|
| β-Nickel hydroxide nanoplatelets | Relative stability in alkaline medium, the formation of Ni(OH)2/NiOOH redox couple on the electrode surface in alkaline medium, accelerate electron transfer |
|
| SnO2 | A large band gap of 36 eV, catalytic activity, good compatibility and biocompatibility, non-toxic, inexpensive, green material, good chemical stability and medium conductivity |
|
| Ni NPs | Enhance electrode conductivity and surface area, facilitate the electron transfer, improve the detection limit of analyte |
|
| Bi NPs | High surface area |
|
| Au NPs | Finely tunable optical properties, high surface area, capacity for surface modification, superior stability, complete recovery in biochemical redox processes, less toxic |
|
| Quantum dot | Very small size, large specific surface area, excellent biocompatibility, quantum cavity electrochemical conductivity |
|
| Nanozeolite | High exchange ability, adsorption capacity, increased surface area, decreased diffusion path lengths, presence of more pore entrances per weight amount of zeolite, enhanced diffusion rates and reactivities |
|
| Metal–organic framework nanostructure | Extensive porosity, tunable pore sizes, large internal surface area and high degree of crystallinity, good chemical stability in aqueous media and electrochemical oxidation/reduction capability |
|
| Y2O3 nanoparticles supported on nitrogen-doped reduced graphene oxide (Y2O3NPs/N-rGO) | Available nitrogen sources, biocompatible C–N microenvironment, the low production cost, high electrical conductivity and many chemically active sites |
|
| Reduced graphene oxide/ZnO nanocomposite (rGO/ZnO-NC) | Wide band gap, non-toxicity, large surface area, excellent conductivity and electrocatalytic activity |
|
| Mesoporous silica nanoparticles (MSNs) | Very high specific surface areas, good adsorption of several species, intrinsic electrocatalytic activity |
|
| SnO2–Co3O4@rGO nanocomposite | Large electroactive surface area and good electrical conductivity |
|
| Al2O3-supported palladium nanoparticles (PdNPs@Al2O3) | High mechanical strength and compressive strength of Al2O3-supported |
|
| Carbon ionic liquid/ion imprinted polymeric nanobeads (IIP-CIL) | High potential and selectivity in trace and ultratrace analyses, high adsorption capacities, improved sensitivity, high stability and durability against harsh chemical environments |
|
| Poly(methylene disulfide) nanoparticles (PMDSNPs) | The presence of S–S bonds in their main chains, the ability to interact with silver ions |
|
| Magnetic silver ion imprinted polymer nanoparticles (mag-IIP-NPs) Fe3O4@SiO2@IIP | Simple and convenient to prepare, high selectivity, fast mass transfer, high surface area and good sorption capacity |
|